Lataa...
Pre-clinical and clinical development of a multi-envelope, DNA-Virus-Protein (D-V-P) HIV-1 vaccine
The human immune system has evolved to recognize antigenic diversity, a strength that has been harnessed by vaccine developers to combat numerous pathogens (e.g. pneumococcus, influenza virus, rotavirus). In each case, vaccine cocktails were formulated to include antigenic variants of the target. To...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2649747/ https://ncbi.nlm.nih.gov/pubmed/19241253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08830180802495605 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|